Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Akorn AKRX is 13.00%. Akorn's EPS for the same period is $0.46. The trailing-twelve-month return on assets at Salix Pharmaceuticals SLXP is 6.40%. Salix's revenue for the same period is $1.12 billion. The trailing-twelve-month return on assets at Mallinckrodt plc MNK is 2.50%. Mallinckrodt's operating margin for the same period is 9.20%. The trailing-twelve-month return on assets at Hospira HSP is 1.00%. Hospira's PEG ratio is 5.78.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDrugs-Generic IndustryMid-CapROA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!